Biography

About

Evan Aftosmes is a Manager at Acumetis with expertise in innovative access strategies across immunology, cardiometabolic, and rare disease. He partners with biopharmaceutical manufacturers to design patient-centric access models, evaluate novel stakeholder partnerships, and address evolving payer, provider, employer, and patient needs. Prior to Acumetis, Evan worked in HEOR and market access reimbursement within the medical device industry. He holds an MPH from the UNC Gillings School of Global Public Health and a BS in Economics from the University of Pittsburgh.

Back to Expertise
Authored Posts

Published works and authored insights

dte thumbnail
July 23, 2026
Direct-to-employer drug models: From niche access model to channel strategy
Discover the market forces driving direct-to-employer adoption and what makes therapies strong candidates for direct commercialization.
June 16, 2026
Evaluating direct-to-employer as an alternative access channel for manufacturers
Learn how Acumetis evaluated a direct-to-employer strategy, identify partnership opportunities, and develop a roadmap to support GTN improvement and future commercialization decisions.
Two nurses filling prescriptions in pharmacy
May 26, 2026
The “direct” continuum: Decoding direct-to-patient and direct-to-employer for commercial success
Explore how DTP and DTE models are reshaping commercialization, improving patient access, affordability, engagement, and market strategy.
Blurry photo of people walking across crosswalk
April 6, 2026
Why direct-to-patient is not one-size-fits-all
Explore scalable direct-to-patient (DTP) models that improve affordability, time-to-therapy, and patient engagement with a strategic, data-driven approach.